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THE ROLE OF LAPAROSCOPY AND ULTRASONOGRAPHY
IN PANCREATIC HEAD CARCINOMA
ABSTRACT
John, T.G., Greig, J.D., Carter, D.C and Garden, O.J. (1995) Carcinoma of the
pancreatic head andperiampullary region. Annals of Surgery; 221: 156-164.
Objective: The authors performed a prospective evaluation of staging laparoscopy
with laparoscopic ultrasonography in predicting surgical resectability in patients with
carcinomas of the pancreatic head and periampullary region.
Summary Background Data: Pancreatic resection with curative intent is possible in a
select minority of patients who have carcinomas of the pancreatic head and
periampullary region. Patient selection is important to plan appropriate therapy and
avoid unnecessary laparotomy in patients with unresectable disease. Laparoscopic
ultrasonography is a novel technique that combines the proven benefits of staging
laparoscopy with high resolution intraoperative ultrasound of the liver and pancreas, but
which has yet to be evaluated critically in the staging of pancreatic malignancy.
Methods: A cohort of 40 consecutive patients referred to a tertiary referral center
and with a diagnosis of potentially resectable pancreatic or periampullary cancer
underwent staging laparoscopy with laparoscopic ultrasonography. The diagnostic
accuracy of staging laparoscopy alone and in con]unction with laparoscopic
ultrasonography was evaluated in predicting tumor resectability (absence of peritoneal
or liver metastases; absence of malignant regional lymphadenopathy; tumor confined
to pancreatic head or periampullary region).
Results: "Occult" metastatic lesions were demonstrated by staging laparoscopy in 14 pa-
tients (35%). Laparoscopic ultrasonography demonstrated factors confirming unresectable
tumor in 23 patients (59%), provided staging information in addition to that oflaparoscopy
alone in 20 patients (53%), and changed the decision regarding tumor resectability in 10
patients (25%). Staging laparoscopy with laparoscopic ultrasonography was more specific
and accurate in predicting tmnor resectability than laparoscopy alone (88% and 89%
versus 50% and 65%, respectively).
Conclusions: Staging laparoscopy is indispensable in the detection of "occult" intra-
abdominal metastases. Laparoscopic ultrasonography improves the accuracy of
laparoscopic staging in patients with potentially resectable pancreatic and
periampullary carcinomas.
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PAPERDISCUSSION
The incidence of the pancreatic carcinoma has in-
creased in the last years and malignant lesions of
the pancreas, especially of the pancreatic head and
periampullary region, constitute a major problem in
surgical practice. Most patients exhibit local inva-
sion of the tumor and metastatic spread by the time
symptoms occur. Nevertheless, fortunately, the par-
tial duodeno-pancreatectomy (Whipple procedure)
can be performed safely with a low morbidity and
mortality rate 1. Although surgical resection of
the tumor is often the only prospect for prolonged
survival if the tumor can be removed entirely,
resectability rates still remain rather low. They do
not exceed over 30% of all patients suffering from
malignancy in the pancreatic gland, although the
rate of resection has been increasing in the last years.HPB INTERNATIONAL 187
The low resectability rates are due to local invasion of
the tumor into adjacent structures, such as vessels,
duodenum, gastric bowel and distant metastases.
The question therefore remains how to avoid
"non-therapeutic" needless laparotomy in these pa-
tients by safely assessing resectability preoperatively
with simple non-invasive means.
Unfortunately, the pancreatic gland is difficult to
assess by imaging procedures due to its anatomic
localization. Consequently, various imaging pro-
cedures, invasive, non-invasive or semi-invasive have
been employed. Among them ultrasonography, CT-
scan and ERCP have proven to be useful, repeatable
and relatively inexpensive. However, all of these
procedures have their limitations especially
concerning not so much the diagnosis of pancreatic
carcinoma but its surgical resectability. All too often
in the past, patients underwent laparotomy for
pancreas tumor and were found to be irresectable.
We and many of the surgeons believe that selective
coeliac angiography is a valuable tool in defining locally
advanced tumors as demonstratedby infiltration, stenosis
or occlusion of the extrapancreatic arteries and veins.
Besides predicting tumor unresectability it also provides
information about possible vasculur anomalies which
are present in about one third ofthe patients.
Recently, several new, more invasive methods for
diagnosis and assessment ofpancreatictumorshavebeen
described. Among them, endoscopicultrasonography is
able to assess the size ofthe tumor, thus tumor stage and
the lymph node status. It has been shown that the overall
accuracy is high2.
The purpose of this study was to assess (in a pros-
pective evaluation) staging of the pancreatic carcinoma
by laparoscopy and laparoscopic ultrasonography. In
this study, 40 patients diagnosed as having pancreatic or
periampullary carcinoma, were considered as candidates
for tumor resection. Already in the referral hospitals,
various diagnosticprocedureswereperformed in order to
ensurebyERCP, dynamicCT-scanning, sonography, that
thetumorwouldbe resectable. The authors are aware that
this highly selective group ofpatients introduces a certain
element ofbias, however, itmirrors the clinical situation of
a specialized clinic into which these patients are referred
to after initial diagnosis. The results show that
laparoscopy, a rather invasive method for assessing
resectability ofthe pancreatic tumor, is only reliable ifa
"positive" result is obtained. In this study, laparoscopy
failed to identify local or regional tumor growth in twelve
patients which later on was found intraoperatively. This
results in a specificity of50% and an overall accuracy of
65%. The importance of the method is if during
laparoscopy in combination with biopsy a "positive"
results can be obtained. The same holds true for many
other methods, such as colonoscopy, where only the
positive results that is proven malignancy is of true
diagnostic value. Negative results do not exclude
malignancy or spread ofthe tumor.
In contrast, laparoscopic ultrasonographyshowedan
extreme high specificity and accuracy of 88 and 89%. If
one however critically reviews the results, the authors
have notcompaired this rather invasivemethod with the
less invasive methods such as endosonography.
Moreover, the authors did not open the lesser sac which
by laparoscopic means can be done fast and safely,
unless the patient has previously suffered from other
pancreatic diseases, such as chronic pancreatitis. The
authors found that laparoscopic ultrasonography
altered the staging information ofthe patients, thus the
decision concerning tumor resectability in 10 patients
(25%). From these 10 patients, however, 8 had invasion
of the adjacent superior mesenteric and portal vein.
Ifthe authorshad performed an angiography prior to an
invasive procedure, such as laparoscopy and laparo-
scopic ultrasonography, they most likely would have
also found these alterations excluding resectability.
Therefore, this expensive invasivemethodwas ofbenefit
onlyin2outof40patients. Itremainsthereforequestionable
ifin a large group ofpatients this expensive and invasive
method really adds significantly to the information
necessary to decidewhether atumor is resectable or not.
The methods described in this study, considering
their limitations and possibilities, are ethically only
feasible if they are used just prior to laparotomy. They
might help to avoid unnecessary laparotomies, how-
ever, often although unresectable, the surgeon will
performbypass surgery according to the prognosis ofthe
tumor. Therefore, in doubtful cases one should decide
for the operation since it’s the only treatment with any
curative chance.
Our concept concerning assessment of resectability
includes in the first line the diagnosis of the pancreatic
tumor. The imaging procedures include conventional
ultrasonography, dynamic CT-scan, and ERCP.
Thereafter, unless already unresectability is proven by
the imaging procedures an angiography is performed in
orderto assess the spreadofthetumorinto the vessels and/
or possible vascular anomalities. Lately, this imaging
procedure has been substituted in selective cases by
endoscopic ultrasonography. In our experience, this new
imaging procedure can be used for tumor growth
assessment and also infiltration ofthe vessels adjacent to
the pancreas. Thismethod, in experiencedhands, reaches
a sensitivity and specificity of nearly 90%.188 HPB INTERNATIONAL
In doubtful cases and in patients with high perio-
perative risk, a laparoscopy has been performed and in
most cases the lesser sac was opened and inspected.
With this procedure,wewere able to decrease thenumber
of unnecessary laparotomies significantly. In times of
cost efficiency and limited resources new diagnostic
measures have to be tested against non-invasive cheaper
methods. As stated also by the authors, these new
methods have to be evaluated .against conventional
investigations in prospective comparative studies.
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OPERATIVE VS NON-OPERATIVE MANAGEMENT
IN STERILE NECROTIZING PANCREATITIS
ABSTRACT
Rau, B., Pralle, U., Uhl, W., Schoenberg, M.H. and Beger, H.G. (1995) Management
of sterile necrosis in instances of severe acute pancreatitis. Journal of The American
College of Surgeons, 181." 279-288.
Background: The clinical management of sterile pancreatic necrosis is still a matter of
debate. In this study we analyzed the clinical course and outcome of patients with sterile
necrotizing pancreatitis treated surgically versus nonsurgically.
Study Design: Between May 1982 and December 1993, 249 patients with necrotizing
pancreatitis (NP) entered this study, of which 172 (69 percent) had intraoperatively or
fine needle aspiration-proven sterile NP. One hundred seven of 172 patients underwent
surgery (S group) with necrosectomy and continuous postoperative closed lavage and
65 of 172 were treated by nonsurgical means (NS group).
Results: Median Ranson and admission APACHE II scores were 4.7 (range, 1 to 10)
and 11 (range, 1 to 29) in the S group, significantly higher than those in the NS group
with 3.0 (range, 0 to 6) (p=0.022) and 8 (range, 1 to 23) (p=0.036). After 48 hours of
intensive care treatment, APACHE II scores persisted at 10.5 (range, 1 to 29) in the S
group and decreased to 6 (range, 0 to 15) (p=0.013) in the NS patients. Median C-
reactive protein (CRP) levels on admission were 179 mglL and 68.5 mg/L (p=0.023),
respectively. Within 72 hours, 61 (94 percent) of 65 NS-managed patients responded to
intensive care therapy, whereas organ complications persisted or increased and thus led
to surgery in the S group. Mortality rates were 13.1 percent in the surgically treated
patients and 6.2 percent in the nonsurgically treated patients (p=NS).
Conclusions: Most patients with limited and sterile pancreatic necrosis respond to
intensive care treatment. Indication for surgery in sterile NP should be based on